Literature DB >> 1277536

A novel specific assay of 25-hydroxy vitamin D.

I Bjorkhem, I Holmberg.   

Abstract

The synthesis of 25-hydroxy-[26-2H3]vitamin D3 is described. A fixed amount of this compound (usually 250 ng) is added to a fixed amount of serum (usually 2.5 ml) and the mixture is extracted with a chloroform/methanol mixture. The extract is chromatographed on a Sephadex LH-20 column together with a trace amount of 25-hydroxy-[263H3]vitamin D3. The chromatographic fraction corresponding to 25-hydroxy vitamin D3 is converted into trimethylsilyl ether and the amount of unlabeled 25hydroxy vitamin D3 is determined from the ratio between the mass fragmentographic recording at m/e 131 (base peak of unlabeled 25-hydroxy vitamin D3) and m/e 134 (base peak 25-hydroxy-[26-2H3]vitamin D3). The relative standard deviation of the method was about 5%.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1277536     DOI: 10.1016/0009-8981(76)90384-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Mass fragmentographic determination of cholecalciferol and 25-hydroxycholecalciferol in human serum.

Authors:  B Zagalak; H C Curtius; R Foschi; G Wipf; U Redweik; M J Zagalak
Journal:  Experientia       Date:  1978-12-15

2.  Purification of a cytochrome P-450 from pig kidney microsomes catalysing the 25-hydroxylation of vitamin D3.

Authors:  H Postlind; K Wikvall
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

3.  Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid.

Authors:  H Oftebro; I Björkhem; S Skrede; A Schreiner; J I Pederson
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.